Senti Biosciences Inc (SNTI)
Healthcare
Biotechnology
0.34 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Senti Biosciences Inc (SNTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -43 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -18 | -24 | -35 | -35 | -52 | -41 | -43 | |
| 1.4 | 2.0 | 3.0 | 3.9 | 5.4 | 5.9 | 3.6 | |
| 0.2 | 0.3 | 2.3 | 16 | 9.7 | 1.8 | 5.7 | |
| -0.1 | -4.5 | 17 | 5.7 | – | – | – | |
| 0.1 | -1.8 | 0.6 | 14 | 4.7 | 4.0 | 3.6 | |
| 2.0 | 1.2 | 5.5 | 41 | 12 | 0.0 | 0.2 | |
| 3.8 | 11 | -5.5 | -82 | 30 | 0.0 | -0.2 | |
| – | – | 0.0 | 5.2 | 0.4 | – | – | |
| – | – | – | 0.2 | 0.5 | – | – | |
| 8.0 | 8.0 | 0.0 | 5.2 | -0.1 | 0.0 | – | |
| 14 | 38 | 68 | 119 | 0.8 | 54 | 12 | |
| 5.8 | 25 | 28 | 1.7 | -22 | 12 | -32 | |
| -20 | -25 | -40 | -76 | -64 | -41 | -44 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.